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GRAY MATTER VOLUME DIFFERENCES OF ADULT MIGRAINE 
PATIENTS USING VOXEL-BASED MORPHOMETRY 
ANDREA ESCOBAR 
ABSTRACT 
Background: Migraine is a primary headache disorder that has a high prevalence and 
burden of disease throughout the world. Migraine symptoms include throbbing head pain, 
nausea, hypersensitivity to light, sound, and smell, and autonomic, cognitive, emotional, 
and motor disturbances. About a third of migraineurs have aura symptoms, which are 
transient neurological symptoms with gradual onset before the migraine attack, visual 
disturbances, sensory loss, and/or communication impairment. The trigeminovascular 
system, central descending modulation, and brainstem descending modulation have been 
implicated in the pathophysiology of migraine. However, the exact neurovascular 
mechanism for migraine has not been determined. Several imaging techniques have been 
used to find structural and functional brain changes in migraineurs. 
Objective: In order to further existing knowledge of migraine pathophysiology, 
structural brain differences were investigated using imaging between migraineurs and 
healthy individuals and differences within migraineurs. 
Methods: Thirty-two patients with migraine (25 females) and 32 healthy control subjects  
(25 females) age-, ethnicity-, and gender-matched participated in our study. Magnetic 
resonance imaging (MRI) scans were collected from each participant. Then, voxel-based 
morphometry (VBM) was utilized to find any gray matter (GM) volume differences 
between migraine patients and controls. Also, VBM was performed in specific regions- 
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of-interest (ROIs) to compare 11 migraine patients with aura (MA) and 11 migraine 
patients without aura (MO). 
Results: A significant increase in regional gray matter volume difference was observed 
for migraine patients compared to control subjects in the intracalcarine gyrus of the visual 
cortex (corrected, p<0.05). In the VBM analysis of ROIs, the similarities between the 
MO and MA subjects included increases in the anterior cingulate cortex (ACC), 
hippocampus, insula, and intracalcarine cortex, along with decreases in the ACC and 
insula (uncorrected, p<0.05). MO subjects had decreases in the amygdala, hippocampus, 
intracalcarine cortex, and thalamus, but not in the MA subjects (uncorrected, p<0.05). 
The MA patients had increases in the amygdala and thalamus, but not in the MO patients 
(uncorrected, p<0.05). 
Discussion: It can be concluded that the visual cortex is involved in the migraine 
mechanism since a large increase in GM volume difference was found in migraine, MO, 
and MA cohorts, as well as results from previous studies. Numerous GM volume changes 
in MO and MA cohorts reinforce evidence that particular brain regions are a part of 
migraine pathophysiology, but there were some regions that do not. Further research 
using imaging analysis and with larger study populations should be conducted to enhance 
our understanding of the migraine mechanism and differences that arise between 
migraine groups, so that diagnosis and treatment administration can be improved. 
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INTRODUCTION 
Migraine headache is classified as a primary headache disorder with a high 
prevalence and high burden of disease ("The International Classification of Headache 
Disorders, 3rd edition (beta version)," 2013). According to the WHO Atlas of Headache 
Disorders, more than 10% of the world population have migraine and 1.7-4% of adults 
have headaches on 15 or more days per month (WHO & Burden, 2011). Across the 
world, 1.3% of all years of life lost to disability is due to migraine. Social interactions, 
family relationships, and employment are negatively affected by recurring headaches. 
The high burden of pain causes people who have headaches to seem irresponsible, to be 
passed up for promotion, to suffer diminished quality of life, and to face lessened career 
and financial advances. The public regards headache disorders as not a serious health 
concern because headaches are not infectious, usually episodic, and not fatal. There are 
several types of migraine including migraine without aura (MO), migraine with aura 
(MA), and chronic migraine. 
 
Types of Migraine  
MO is a recurrent headache with several attacks occurring between 4 and 72 
hours that is worsened by and/or causing avoidance of everyday physical activity ("The 
International Classification of Headache Disorders, 3rd edition (beta version)," 2013). 
Usually the headache is located frontal-temporally with unilateral placement in adults and 
late adolescents, but bilateral placement in children and adolescents. The headache is of 
moderate to severe intensity with at least one of the following occurring: (a) nausea 
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and/or vomiting, (b) photophobia and phonophobia. Also, MO is correlated with cranial 
autonomic symptoms (e.g. nasal congestion) and cutaneous allodynia (pain triggered by a 
harmless stimulus to normal skin (Landy et al., 2004). Furthermore, it is often associated 
with menstruation ("The International Classification of Headache Disorders, 3rd edition 
(beta version)," 2013). 
Patients diagnosed with MA experience temporary focal neurological symptoms 
before or during a headache, along with similar symptoms of MO ("The International 
Classification of Headache Disorders, 3rd edition (beta version)," 2013). These fully 
reversible central nervous system symptoms occur unilaterally and carry on for minutes 
to an hour. Also, aura symptoms are visual, sensory, motor, speech, language, brainstem, 
and/or retinal with visual symptoms being the most prevalent, followed by sensory 
disruptions such as paresthesia (tingling, pricking, tickling, or burning sensation of the 
skin). A premonitory phase and a headache resolution phase accompany MA with 
symptoms of depression, hyperactivity, hypoactivity, yawning, fatigue, food cravings, 
and neck stiffness and/or pain. Further, the premonitory phase includes light and/or sound 
sensitivity, trouble concentrating, blurry vision, pallor, and nausea. MA patients can have 
MO as well. 
In chronic migraine, headache occurs on 15 or more days per month for greater 
than 3 months with attacks characteristic of migraine on 8 or more days per month ("The 
International Classification of Headache Disorders, 3rd edition (beta version)," 2013). 
These migraine headaches can be with or without aura. If the patient is taking medication, 
s/he should describe the headache as a migraine at onset but was then relieved by ergot or 
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triptan medication. The headache severity and duration may fluctuate from day to day or 
within the same day and it may be difficult to keep the patient drug-free. In order to 
distinguish between chronic migraine and medication-overuse headache, if the patient 
undergoes medication withdrawal and still has chronic migraine then the patient can be 
diagnosed with chronic migraine. 
 
Neurobiology of Migraine 
Genetics 
Population-based epidemiological surveys and twin studies greatly support the 
idea that MO is produced by genetic and environmental influences (Goadsby, 2013). 
Epidemiological evidence demonstrates methyltetrahydrofolate reductase C677T gene 
mutation is over-prevalent in people with MA (Goadsby, 2013). Other population-based 
epidemiological information indicates that there is no additional risk in cognitive function 
for migraineurs when compared to sex- and age-matched controls. 
About 50% of reported families who experience migraine have Familial 
Hemiplegic Migraine I (FHM I) which are mutations in chromosome 19p13 (Goadsby, 
2013). These mutations comprise Cav2.1 (P/Q)-type voltage-gated calcium channel 
CACNA1A gene (Ophoff et al., 1996). Chromosome 19-linked and unlinked FHM 
families are similar clinically. Cerebellar ataxia is one clinical trait that does associate 
with chromosome 19 mutations in about 50% of cases, but is not connected to unlinked 
families. Also, chromosome 19-linked families may have migraine attacks generated by 
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minor head trauma or correlated with coma, but these differences are less prominent than 
cerebellar ataxia. 
ATP1A2 mutations have been found to cause approximately 20% of FHM 
families and have been designated as FHM II (De Fusco et al., 2003) in which epilepsy 
also occurs (Jurkat-Rott, 2004). The normal ATP1A2 gene codes for Na+/K+ ATPase 
(De Fusco et al., 2003). The mutation causes a smaller electrochemical gradient for Na+ 
ions that decreases or shuts down astrocystic glutamate transporters, resulting in an 
accumulation of synaptic glutamate (Goadsby, 2013). 
The FHM III missense mutation, Q1489K in SCN1A, is described in 3 German 
families (Dichgans, 2005). A highly conserved glutamine is replaced by lysine in an area 
of the voltage-gated sodium channel that participates in the hyperpolarization after 
membrane depolarization. Thus, this mutation prevents a rapid closure which creates a 
continuous influx of sodium (Goadsby, 2013).  
As indicated by genetic studies, migraine, particularly MA, may be a 
channelopathy such as dysfunctional noradrenergic and serotonergic channels in the locus 
coereleus (LC) and dorsal raphe nucleus (DRN), respectively (McMahon et al., 2013). 
Further, channel dysfunction has been connected to aura in a study that created a knock-
in mouse with a CACNA1A missense mutation that caused an increased susceptibility to 
CSD by a reduced threshold and increased velocity of CSD (van den Maagdenberg et al., 
2004). These knock-in mouse models were employed in other studies to observe 
nociceptive activation of trigeminal dura utilizing Fos protein expression. In contrast to 
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wild-type animals, second order neuronal activation was reduced and Fos protein 
expression was increased in particular thalamic nuclei (Goadsby, 2013). 
 
Trigeminovascular Anatomical Pain Pathway 
 Although precedence of either vascular or neuronal components have not been 
determined from clinical and experimental studies, the trigeminal system has been 
implicated in the generation of migraine pain (Tajti, 2012). Pain sensitivity in the skull 
mainly occurs in large cerebral blood vessels, blood vessels in the pia and dura mater, 
and large venous sinuses which are surrounded by the peripheral branches of non-
myelinated (C-fibers) and thinly myelinated (Aδ fibers) axons that have vasoactive 
neuropeptides from the ophthalamic division of the trigeminal ganglion and in the 
posterior fossa from upper cervical dorsal roots (Akerman, 2011; Pietroban & Striessnig, 
2003; Tajti, 2011). CSD, CGRP (calcitonin-gene related peptide), PACAP (pituitary 
adenylate cyclase activating peptide), and NO (nitric oxide) activate the peripheral 
branches of the trigeminal nerve. 
The afferents from the trigeminal ganglion and from the greater occipital nerve 
through the cervical ganglion project to second-order neurons in the brainstem in an area 
called trigeminal cervical complex (TCC) (Akerman, 2011; Tajti, 2011). There is a 
convergence of intracranial and extracranial primary afferents onto the TCC that may 
contribute to pain perception specified in the periorbital and occipital regions (Noseda & 
Burstein, 2013). The TCC neurons travel through the quintothalamic tract (carries 
sensory information from the head and face through the trigeminal nucleus), cross in the 
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brainstem, and synapse with the thalamus. Functionally identified TCC neurons project to 
the anterior hypothalamus, lateral hypothalamus, perifornical hypothalamic areas, 
parabrachial area, zona incerta, lateral preoptic nucleus, and ventral posteromedial 
(VPM), posterior (Po), and parafascicular (Pf) thalamic nuclei. Most of the second-order 
TCC projections end in the ventrolateral periaqueductal gray matter (PAG), rostral 
trigeminal spinal nuclei, nucleus of solitary tract, brainstem reticular areas, and the 
cuneiform nuclei (Noseda & Burstein, 2013). Also, parasympathetic outflow to the 
cranium occurs from the TCC neurons connected to the superior salivatory nucleus (SSN) 
in the pons which links to cranial vasculature through the sphenopalatine ganglion 
(Akerman, 2011).  
TCC projections to brainstem structures (i.e. LC and PAG) and higher order 
structures (i.e. thalamus and hypothalamus) then send signals to the cortex. The thalamus 
is the main area where nociceptive inputs go through to reach the cortex. VPM dura-
sensitive neurons travel to the primary and secondary somatosensory cortices and the 
insula which indicates involvement in sensory-discriminative migraine elements like 
intensity, location, and quality of pain. Other dura-sensitive projections from the posterior 
(Po) and lateral posterior/dorsal thalamic nuclei end in several cortical areas like 
somatosensory, visual, auditory, motor, parietal, retrosplenial, and olfactory cortices. 
These areas show involvement with allodynia, photophobia, phonophobia, motor 
clumsiness, difficulty focusing, transient amnesia, and osmophobia.  
 The cortex sends descending projections to the thalamus, hypothalamus, and LC.  
Hypothalamic nuclei, such as the A11 dopaminergic nucleus, project to the TCC neurons. 
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Also, the TCC receives descending modulation from the PAG through the rostral 
ventromedial medulla (Akerman, 2011). 
 
Peripheral and Central Sensitization 
Clinical and animal studies provide indirect evidence that the abundance of 
inflammatory mediators released during migraine have the ability to maintain activation 
and sensitization of peripheral and central trigeminovascular (TGV) neurons (Noseda & 
Burstein, 2013). Peripheral sensitization (PS) is an increased sensitivity to innocuous or 
noxious stimulation by an over response of primary afferent fibers, causing a throbbing 
perception. In support of peripheral sensitization, clinical studies have found an increased 
amount of inflammatory mediators in cephalic venous outflow during migraine, as well 
as the acute migraine treatment with efficacious NSAIDs (Pietroban & Moskowitz, 
2013). In animal studies, in vivo meningeal nociceptor activation caused peripheral nerve 
endings to release vasoactive proinflammatory peptides like CGRP and substance P. 
These peptides cause neurogenic inflammation which entails meningeal blood vessel 
vasodilation, localized activation of mast cells from the dura, plasma protein 
extravasation, and cytokine and other inflammatory mediator release (Pietroban & 
Moskowitz, 2013). Rat dural nociceptors showed palpable cephalic hypersensitivity as 
well as long-lasting activation and sensitivity due to dural mast cell degranulation. The 
process behind PS and inflammation during migraine has not been fully elucidated. 
About two-thirds of migraineurs experience cutaneous allodynia (CA) in the 
periorbital region that could spread to extracephalic regions after the onset of headache. 
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CA is pain perception from harmless stimuli and is a sign of central sensitization (CS). 
Once an inflammatory soup (blend of prostaglandins, potassium, histamine, bradykinin, 
and serotonin causing hyperalgesia) was applied locally to the dura of anesthetized 
animals, second order TGV neurons in the TCC displayed greater and longer lasting 
responses to harmless mechanical or thermal facial skin stimulation (Strassman et al., 
1996). Also, third order TGV neurons in the posterior thalamus presented increased and 
long-lasting responses to whole body skin stimulation. In an fMRI study of migraine 
patients, innocuous heat and brush stimuli generated a large blood oxygen-level 
dependent (BOLD) signal in the thalamus of migraineurs showing signs of whole-body 
allodynia, such as not being able to wear tight clothing or unable to take showers, during 
a migraine attack versus a pain-free state (Burstein et al., 2010). After chemical 
stimulation of rat dura, investigators gave an anesthetic block of primary dural afferents 
which did not prevent long-lasting hypersensitivity to skin stimulation of TCC neurons. 
This result indicates that CS is independent of afferent input after it has been initiated. 
 
CSD & Migraine with Aura 
 In about a third of migraine patients, focal neurological disturbances known as 
auras are experienced as visual, motor, or sensory symptoms. Many studies have 
established aura in humans is analogous to CSD of Leão in other animals (Charles & 
Baca, 2013). CSD, cerebral spreading depression, is a wave of activity that moves across 
the surface of the brain slowly, as described in several diverse animal models ( Leão, 
1944a, 1944b, 1947; Leão & Morison, 1945). For instance, a wave of depolarization was 
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observed as a massive shift in direct current (DC) which was then followed by a 
spreading suppression or “depression” of spontaneous EEG activity. The wave of 
depolarization is seen in glial cells and neurons with a great rise in extracellular K+, 
decrease in extracellular Na+, among other changes in ion concentrations (Hansen & 
Zeuthen, 1981; Dietz et al., 2008; Mutch & Hansen, 1984). These ion fluxes can cause 
cellular swelling that may change the extracellular environment. Almost all areas of the 
brain can exhibit CSD (Leão, 1947). 
 Visual aura in humans alters the visual field that begins at the center of the field 
and moves to the outside at 3 mm/min (Goadsby, 2013). This phenomenon has been 
mapped onto areas believed to correspond to the occipital cortex which resembles the 
spatial and temporal aspects of CSD in rabbits (Charles & Baca, 2013). In MA patients, 
spatial patterns of DC switching was observed when using magnetoencephalography that 
proposes the involvement of CSD (Bowyer et al., 2001). Sustained aura can be alleviated 
by ketamine, a validated agent for blocking CSD in animals (Goadsby, 2013). However, 
the standard electrophysiological characteristics of CSD have not detected in subjects 
who experience migraine. Further, there were no significant changes in surface EEG 
recordings with scalp electrodes while aura was occurring (Lauritzen et al., 1981).  
 In migraine patients, functional imaging studies have shown changes in blood 
flow and cortical activity, with congruous temporal and spatial features to CSD. CT 
images of MA-induced in patients exhibited a wave of oligaemia, then hyperaemia, in 
large regions of the center (Olesen et al., 1990). A case study of an MO patient using 
positron emission tomography, PET, also displayed oligaemia when a migraine headache 
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present (Woods et al., 1994). CSD is indicated in migraine since the changes in blood 
flow and cortical function in patients with MO and MA show a pattern of propagation 
throughout the brain. 
 Another debate is whether pain is experienced with CSD. In animal models, pain 
pathways may be activated or sensitized when messengers, such as nitric oxide (Colonna 
et al., 1997; Obrenovitch et al., 2002), ATP (Schock et al., 2007), CGRP (Colonna et al., 
1994; Reuter et al., 1998; Tozzi et al., 2012; Wahl et al., 1994), and high-mobility group 
protein B1 (Karatas et al., 2013), are released while CSD is occurring. 
Electrophysiological neuronal recordings in the trigeminal ganglion and brainstem, along 
with immunohistological c-Fos labelling in the brain stem, demonstrate trigeminal 
nociceptive neuron activation during CSD (Zhang et al., 2010, 2011). However, N-
methyl-D-aspartate given to awake rats causes a CSD occurrence and freezing behavior, 
but not ultrasonic vocalization associated with extreme pain (Akcali et al., 2010). A 
different study observed facial expressions indicating pain when KCl was employed to 
evoke CSD (Karatas et al., 2013).  
 
Neural Mechanisms behind Migraine Photophobia 
Photophobia specifies light-induced neurological symptoms including exacerbation of 
headache, hypersensitivity to light, and ocular discomfort/pain (photo-oculodynia)  
(Noseda & Burstein, 2013). Thus, ambient light exposure aggravates the perception of 
migraine headache (Kawasaki & Purvin, 2002; Liveing, 1872) and is experienced by 
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about 90% of migraineurs with normal eyesight (Liveing, 1872; Selby & Lance, 1960; 
Drummond, 1986). 
Observations in blind migraine patients indicates that photophobia is reliant on photic 
signals from the eye that synapse with TGV neurons somewhere along its path (Noseda 
& Burstein, 2013). Migraine patients who do not have visual perception due to complete 
optic nerve damage testify that light does not hurt them during a migraine attack, their 
sleep cycle is irregular, and light does not induce pupillary response. However, headache 
exacerbation is still experienced in blind migraineurs with intact optic nerve and partial 
light perception, but have no sight because of severe degeneration of rod and cone 
photoreceptors (Noseda et al., 2010a). 
Retinal projections are composed of two physiologically different routes to the brain. 
One pathway forms images by photoactivation of rods and cones (Noseda & Burstein, 
2013). The other regulates biological functions like pupillary reflex, circadian 
photoentrainment, and melatonin release by activating photosensitive retinal ganglion 
cells containing melanopsin photoreceptors (Klein & Weller, 1972; Freedman et al., 
1999; Lucas et al., 2001). All retinal photoreceptors presumably contribute to migraine-
type photophobia in migraineurs with normal eyesight (Noseda & Burstein, 2013). 
The speculated neural mechanism for headache exacerbation is the convergence 
of photic signals from retina onto TGV thalamo-cortical pathway (Noseda et al., 2010a). 
Light heightens thalamic TGV neuron activation. Also, retinal ganglion cells directly 
transmit signals to a subgroup of neurons sensitive to light/dura that are situated in the 
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posterior thalamus. The axonal projections of these neurons lead to cortical areas 
associated with pain processing and visual perception.  
A mechanism for photo-hypersensitivity proposes that TGV nociceptive signals 
during a migraine attack enter the visual cortex through the light/dura-sensitive neurons 
in the posterior thalamus which then responds differently to visual stimuli and becomes 
hyperexcitable in migraineurs. However, TGV nociception may not be the only pathway 
to contribute to visual cortex hyperexcitability since this hyperexcitability persisted 
during a migraine attack and after headache relief, but not during the interictal period 
(Denuelle et al., 2011).  
Photo-oculodynia could come from indirect activation of a pathway that includes 
the olivary pretectal nucleus, SSN, and sphenopalatine ganglion (Okamoto et al., 2010). 
These areas parasympathetically regulate vasodilation and mechanical changes in ocular 
blood vessels. These responses activate trigeminal nociceptors and second order 
nociceptive neurons in spinal trigeminal nucleus. Yet, there is no evidence that light 
evokes vasodilation in the human retina (Noseda & Burstein, 2013).  
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Figure 1. Photophobia Mechanism. Proposed mechanisms for A) exacerbation of 
headache by light, B) light hypersensitivity in migraineurs, and C) light-induced ocular 
pain (Noseda & Burstein, 2013). 
 
Central Descending Modulation of Trigeminovascular Pain 
 Trigeminal nociception may be modulated internally, beginning in the cortex like 
most pain relay networks in the CNS (Noseda & Burstein, 2013). Cortical dysexcitability, 
fluctuations in cortical excitability, has been shown to greatly influence vulnerability to 
migraine attacks (Ayata et al., 2006; Coppola et al., 2007; Vecchia & Pietrobon, 2012; 
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Lang et al., 2004; SK & F, 2007; Werhahn et al., 2000), but the mechanism is unknown. 
Some studies have indicated that certain areas in the cortex and the level of excitability in 
those areas may contribute to migraine pain development in the pathways from the cortex 
to the trigeminal system. For instance, direct descending projections have been 
anatomically distinguished from the cerebral cortex to the spinal trigeminal nucleus in 
rats (Desbois et al., 1999; Jacquin et al., 1990; Noseda et al., 2010b) and in human beings 
(K. HG, 1958). In Noseda et al 2010, CSD starting in the primary somatosensory cortex 
caused inhibition of meningeal-induced responses, whereas CSD triggered in the insula 
caused facilitation of meningeal-induced responses (Noseda et al., 2010b). CSD 
generated in the primary visual cortex caused the primary somatosensory cortex to inhibit 
and the insula to augment meningeal-induced responses of the TCC. 
 
Hypothalamic Descending Modulation of Trigeminovascular Pain 
The hypothalamus has been implicated in various facets of migraine. 
Hypothalamic activation was observed during spontaneous migraine attacks in a study 
using PET scans of migraine sufferers (Denuelle et al., 2007). The hypothalamus is 
involved in regulating the endocrine and autonomic nervous system (Saper, 2002). 
Premonitory symptoms for migraine, like irritability, sleep-wake cycle disturbances, 
urination, food cravings, and thirst (Giffin et al., 2003), are linked to hypothalamic action 
(Wisse, 2013). Also, studies show c-fos expression in hypothalamic nuclei after dural 
stimulation (Benjamin et al., 2004; Malick et al., 2001) and hypothalamic nuclei is 
anatomically connected to spinal trigeminal nucleus (Malick & Burstein, 1998; Gauriau 
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& Bernard, 2004; Malick et al., 2000; MB, 1976; Robert et al., 2013; Swanson & 
McKellar, 1979). Hypothalamic modulation may apply direct and indirect projections to 
the spinal and medullary dorsal horn by liberating neuropeptides such as somatostatin, 
oxytocin, dopamine, and orexin (Holland, 2009; Rojas-Piloni et al., 2007; Jones & 
Gebhart, 1988; TA, 1993; Yirmiya et al., 1990). 
 
Brainstem Descending Modulation of Trigeminovascular Pain 
 The PAG is thought to be a “migraine generator” ever since it was reported that 
patients experienced migraine-like pain after receiving an electrode implantation near the 
PAG (Raskin et al., 1987). Also, the first study to demonstrate brainstem activation in 
spontaneous migraine put forth the notion that migraine pathogenesis is connected to 
imbalanced regulation of antinociception and vascular control by the brainstem (Weiller 
et al., 1995). However, there is a lack of evidence to conclude that the PAG is a 
“migraine generator” (Borsook & Burstein, 2012). 
 Dysfunctional brainstem nuclei, such as the PAG, is speculated to increase 
neuronal activity that promote TGV pain processing in the spinal and medullary dorsal 
horn that creates migraine-like pain (Noseda & Burstein, 2013). PAG projects less to the 
spinal and medullary dorsal horns and more to the RVM (Basbaum, A. I. & Fields, H. L., 
1978; Fields et al., 1995; Holstege & Kuypers, 1982; Mason, 2005). Thus, neurons in the 
RVM directly associated with descending modulation by RVM projections to the spinal 
and medullary dorsal horns. One study showed that migraine pain was invoked by 
facilitatory effects in the RVM (Edelmayer et al., 2009). Therefore, the PAG may not 
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have inhibited the RVM, unlike its normal function such as when stimulation of the PAG 
inhibited activity of the spinal trigeminal nucleus (Knight & Goadsby, 2001). 
 Another area in the brainstem that may be involved in the modulation of migraine 
is the dorsolateral pons that is made up of the cuneiform nucleus, inferior colliculus, LC, 
mesencephalic trigeminal nucleus, principal sensory trigeminal nucleus, parabrachial 
area, and vestibular nucleus (Afridi et al., 2005b; Bahra et al., 2001; Moulton et al., 2008; 
Stankewitz et al., 2011; Weiller et al., 1995). 
 
Imaging Analyses Utilized in Migraine Research 
 Functional neuroimaging techniques can be used to investigate neurological and 
psychiatric diseases. The functional activity in particular regions in the brain may help to 
further elucidate migraine pathophysiology in humans. PET and MRI are commonly used 
neuroimaging techniques, including in migraine research. PET scans require radioactive 
material to assess organ or tissue metabolism which will provide both physiological and 
anatomical information about the organs or tissues being scanned ("Positron Emission 
Tomography (PET Scan)," 2015). Therefore, PET may find disease onset before 
anatomical differences of a disease appear in other imaging procedures like computed 
tomography (CT) and MRI. Several PET studies have been conducted investigating 
headache and migraine. One study found an increase in regional cerebral blood flow in 
the rostral brainstem that continued after the administration of sumatriptan which 
completely relieved headache, photophobia, phonophobia, and nausea (Weiller et al., 
1995). Afridi et al examined 5 patients employing H2O
15-labelled PET during a 
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spontaneous migraine attack and found dorsal pontine activation (Afridi et al., 2005b). 
They also did a PET study in 24 patients experiencing migraine evoked by nitroglycerine 
which showed ipsilateral activation in the dorsal pons in unilateral migraine and bilateral 
activation during bilateral headaches (Afridi et al., 2005a). Functional MRI (fMRI) 
measures blood flow changes in capillary beds by determining relative differences in 
hemoglobin and deoxyhemoglobin concentrations (Borsook et al., 2006). The different 
paramagnetic features of hemoglobin and deoxyhemoglobin provides the contrast in and, 
thus, the signal of the image. A MRI does not require a radioactive tracer injection, has 
higher temporal and spatial resolution, and has a shorter scan time compared to other 
neuroimaging techniques. In the same subject, fMRI and other functional neuroimaging 
techniques can measure brain activity modifications at several levels of the trigeminal 
system, such as the trigeminal ganglion, trigeminal nucleus, and higher brain centers. 
Thus, fMRIs help assess pain processing pathways and differentiating the functional 
connectivity in the brains of healthy individuals and in those of people with trigeminal 
system dysfunctions. 
 Manual measurements of specific structures and visual evaluations by radiologists 
are conventional methods to analyzing MRI scans (Whitwell, 2009). However, many 
researchers use automated techniques to identify structural and functional differences 
between large subject groups. Two such techniques are diffusion tensor imaging (DTI) 
and voxel-based morphometry (VBM). The signal intensity from DTI is dependent on 
distance and direction of the average water molecule in a voxel moves within 100 ms 
(Alger, 2012). The most prominent microscopic elements in the brain tissue are organized 
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arrays of myelinated axons in white matter (WM). Therefore, WM tracts from one region 
of the brain to another may suggest pathways involved in migraine pathophysiology.  
 VBM usually employs T1-weighted volumetric MRI scans instead of T2-
weighted and performs statistical tests across all voxels in an image to find volume 
differences, either atrophy or expansion of tissue, between groups (Whitwell, 2009). T1-
weighting is a basic pulse sequence and produces varying signal intensities due to 
differences in T1 relaxation times in tissues (Morgan & Jones, 2015). WM and bone have 
a bright contrast in T1 images; GM and CSF have darker contracts. T2 images are 
opposite where GM and CSF have the brighter signal; WM and bone are darker.  
 VBM has been used to investigate many conditions, like epilepsy (Keller & 
Roberts, 2008), neurodegenerative diseases (Whitwell & Jack, 2005), and schizophrenia 
(Radulescu et al., 2014). VBM results are challenging to validate, but studies have shown 
acceptable coherence between VBM analyses, manual measurements, and visual 
assessments for particular structures (Davies et al., 2009; Good et al., 2002; Whitwell & 
Jack, 2005). After MRI scans are collected, all images undergo spatial normalization 
using a customized template made up of the study cohort. Then, modulation is employed 
to correct for volume change that occurred during spatial normalization (Good et al., 
2001). This is done by scaling image intensities by the amount of contraction that 
happened during spatial normalization (Whitwell, 2009). Next, images are smoothed 
according to the size of the smoothing kernel, meaning the intensity in each voxel is 
exchanged for the weighted average of circumferential voxels which blurs the segmented 
image (Good et al., 2001; Ashburner & Friston, 2000). The smoothing step fits data more 
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closely to the Gaussian field model that better normally distributes data, boosting validity 
of parametric tests, and decreasing irregularities between subjects (Ashburner & Friston, 
2000; Salmond et al., 2002). In the statistical analysis, the null hypothesis is that there is 
no tissue volume difference between groups (Whitwell, 2009). Statistical maps are 
created which display voxels that refute the null and show significance to desired p-value. 
Since a large number of voxels undergo statistical tests, studies should correct for 
multiple comparisons to reduce the change of false positives by employing typical 
methods such as the family-wise error (FWE) correction (Friston et al., 1994). Some 
studies instead use a small volume correction to raise the chance of finding significant 
results in specific ROIs in the brain (Whitwell, 2009). ROIs are placed over certain 
structures and analysis is performed in only those regions. ROI placement should be 
driven by a hypothesis and based on previous studies or work. 
 Numerous studies about headache and migraine have been done using VBM, 
sometimes in conjunction with other imaging techniques. On a 2T MRI scanner, Matharu 
et al imaged 11 patients with MA, 11 controls, 17 patients with MO and 17 controls 
(Matharu et al., 2003). No significant differences were found in global GM or WM 
between patients with migraine and controls or between MA patients and MO patients. 
Rocca et al utilized a 3T MRI scanner to T2-weighted and high resolution T1-weighted 
images in 16 migraine patients with T2-visible abnormalities and 15 matched controls 
(Rocca et al., 2006). The T2-weighted sequence was used to identify the abnormalities in 
migraineurs, but the T1-weighted images of both patients and controls were used in the 
VBM analysis. When compared to controls, migraineurs had decreased GM density, 
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primarily in the frontal and temporal lobes, and increased GM density in the PAG. The 
reduced densities in migraine patients were correlated with age, disease duration, and T2-
visible lesion load. Also, MA patients had higher GM density in the PAG and 
dorsolateral pons compared to MO patients. In 2007, a study conducted VBM analyses in 
27 migraine patients (16 episodic and 11 chronic migraineurs) and 27 healthy controls 
(Valfrè et al., 2008). Migraine patients showed significant focal GM reduction in the right 
superior temporal gyrus, right inferior frontal gyrus, and left precentral gyrus. When 
compared to episodic migraineurs, chronic migraine patients had decreased focal GM in 
several areas involved in pain circuitry: the bilateral ACC, left amygdala, left parietal 
operculum, left middle and inferior frontal gyrus, right inferior frontal gyrus, and bilateral 
insula. Further, a significant correlation was seen between migraine attack frequency and 
GM reduction in ACC.  
Another study with 35 migraine patients and 31 healthy controls used a 1.5T MRI 
scanner (Schmidt-Wilcke et al., 2008). The VBM analysis corrected for multiple 
comparisons (P<0.05) found no significant GM changes in migraine patients. However, 
when small volume correction (P<0.05) was employed, migraine patients displayed a 
significant GM decrease in the anterior and posterior cingulate cortex and the right 
insular cortex when compared to controls. Schmitz et al applied VBM and DTI in 28 
female migraine patients and 28 healthy age- and sex-matched controls (Schmitz et al.,  
2008). Fractional anistrophy (FA) was determined from DTI and is a measure of brain 
tissue integrity. Reduced FA values indicate WM fiber loss or water influx because of 
tissue damage. When compared to controls, migraineurs had significantly decreased FA 
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values in the brainstem, cerebellum, superior frontal lobe, and medial frontal lobe. Also, 
migraineurs showed significantly uncorrected GM and WM density decreases in the 
frontal, occipital, and parietal areas, as well as a WM density increase in the superior 
frontal area. Migraine patients with high attack frequency (>3 migraine attacks per 
month), versus those with low attack frequency, had significantly low GM volume in the 
left parahippocampus, left superior frontal gyrus, and inferior parietal lobe. Further, the 
WM volume was decreased in the right frontal lobe and increased in the left parietal lobe. 
Migraineurs with long disease duration (>15 years of migraine attacks), compared to 
patients with short disease duration, had significantly reduced GM volume in the basal 
ganglia and medulla, but significantly increased WM volume bilaterally in the 
cerebellum. Also, patients with long disease duration had significantly reduced FA values 
in the right frontal lobe.  
The Kim et al study compared 20 migraine patients with 33 healthy age- and 
gender-matched controls and observed that migraine patients had significant GM volume 
decrease in the bilateral insula, motor/premotor, prefrontal, cingulate cortex, right 
posterior parietal cortex, and orbitofrontal cortex (P<0.001, uncorrected for multiple 
comparisons and P<0.05, small volume correction) (Kim et al., 2008). These regions had 
progressively decreased GM volume changes in relation to headache duration and 
lifetime headache frequency. Brain regions associated with central pain processing may 
be selectively damaged because of repeated migraine attacks over time.  
Lastly, VBM and functional connectivity analyses were performed in 21 patients 
with MO and 21 healthy age- and sex-matched controls (Jin et al., 2013). Compared to 
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healthy controls, MO patients displayed significantly reduced GM volume differences in 
the left medial prefrontal cortex, dorsal ACC, right occipital lobe, cerebellum, and 
brainstem. The decrease in GM volume of the dorsal ACC was related to longer disease 
duration for migraineurs. Further, there was increased functional connectivity in the left 
dorsal ACC of migraine patients and regions of bilateral middle temporal lobe, 
orbitofrontal cortex, and left dorsal prefrontal cortex. It is possible that frequent 
nociceptive input has changed anatomical and physiological patterns in the frontal cortex 
which may be the reason for functional impairments in migraineurs. 
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Specific Aims 
This study aims to add to the existing knowledge of migraine pathophysiology by 
assessing brain differences between migraineurs and healthy people. In order to 
determine structural brain differences between migraine patients and healthy individuals, 
as well as structural brain differences within migraine patients, the following aims were 
undertaken: 
(1) To assess GM volume differences between migraine patients and healthy age-, 
gender-, and ethnicity-matched controls using VBM. 
(2) To evaluate the similarities and differences in GM volume changes of MO and MA 
patients in particular ROIs by conducting VBM analyses in MA patients compared to 
matched controls and MO patients compared to matched controls. 
 
It is hypothesized: 
(1) A decrease in GM volume difference will be observed for migraine patients, 
compared to controls. 
(2) GM volume differences of the same regions in MA patients will be greater in 
magnitude than that observed in MO patients in comparison to their respective controls. 
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METHODS 
 
Subjects 
A total of 64 subjects were included in this study. This total included 32 patients 
with migraine (mean age=33.34 years, 25 females) and 32 healthy control subjects who 
were age, ethnicity, and gender-matched (mean age=33.34 years, 25 females). Figure 3 
shows that 84 subjects were recruited in this study, 80 enrolled, 7 were excluded based on 
the inclusion/exclusion criteria, 4 withdrew from the study for reasons such as 
claustrophobia while in the MRI scanner, and 5 were removed before analysis because 
the scanned images were not usable. Migraine subjects were recruited from clinics in the 
New England area and through a migraine subject database provided by MedVadis 
Research. Control subjects were recruited by advertising in McLean Hospital recruiting 
website, CRNet, Craigslist, and newspapers. 
Migraine subjects were included in this study if they 1) had a history of episodic 
migraine for at least 3 years, 2) had no other significant medical history, 3) were right-
handed and 4) were between the ages of 18-50. Healthy control subjects were included in 
this study if they 1) were an age, gender, and ethnicity match to a migraine subject, 2) 
had no significant medical history and 3) were right-handed. Subjects were excluded if 
they 1) had significant medical problems (besides pain before, during, or after migraine 
episodes for migraine subjects, 2) had a history of dermatological hypersensitivities in the 
facial area, 3) had a sensory loss detected on Quantitative Sensory Testing at screening, 
or 4) has a Beck Depression Inventory II (BDI-II) score greater than 25 (moderate to 
severe depression). As MRI also involves exclusion criteria for the participant’s safety, 
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subjects were excluded from this study if they reported being claustrophobic or had any 
metal implants/devices. 
 
Image Acquisition 
Subjects went to McLean Hospital Neuroimaging Center for one and/or two visits 
to complete questionnaires, diagnostic exams, and undergo the MRI scan. Whole brain 
3D T1-weighted images were obtained on a 3T Siemens Trio system (Siemens Medical 
Solutions, Erlangen, Germany) using a magnetization prepared rapid gradient echo 
(MPRAGE) sequence (224 slices; TR=2000 ms; TE=3.53 ms; TI=1100 ms; 256×256 
matrix; FOV= 200 mm; 1.0×1.0×1.0 mm voxels).  
 
VBM Processing 
 1. Data was prepared for FSL-VBM. FSL is an analysis tools library for fMRI, 
MRI, and DTI brain imaging data that runs on computers. All the T1-weighted images 
with different code names indicating which group the images belong to were placed into 
a FSL VBM directory. A template list was created with the codes of all subjects. The 
design.mat and design.con was created from the general linear model using higher 
level/non-time series design for two groups unpaired and placed into the FSL VBM 
directory. 
 2. The next step is brain extraction (BET) which prepares images for registration 
and segmentation. BET eliminates non-brain tissues with highly variable contrast and 
geometry such as the scalp and marrow. First, fslvbm_1_bet –b was run, but the BET 
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images included a lot of neck, so then fslvbm_1_bet –N was used. Several images (N=19) 
still had neck tissue, so BET was manually run on those images individually using the 
bias field and neck cleanup option and having f values of 0.2 or 0.7. 
 3. Images were registered where the voxel location becomes the anatomical 
location with accurate values. A study-specific gray matter (GM) template was created 
using the non-linear registration command fslvbm_2_template –n. 
 4. fslvbm_3_proc was run to non-linearly register all GM images to the study-
specific template and integrate them into a 4D image. The images were then modulated 
for the contraction caused by the non-linear of the transformation, integrated into another 
4D image and smoothed with a range of Gaussian kernels (sigma=2, 3, 4mm).  
 
Statistics 
Next, Threshold-free cluster enhancement (TFCE) based analysis using 
randomize was performed with a smoothing sigma=3mm and 5,000 permutations. The  
results in GM were considered significant for P<0.05, FWE corrected. 
 
Sub-analyses 
 In order to determine any differences between migraine patients without aura 
(MO) and migraine patients with aura (MA), sub-analyses were performed using the 
same previously stated FSL VBM protocol for comparing 11 migraine patients with aura 
(mean age=39.91 years, 10 females) to the 11 matched healthy control subjects and 
comparing randomly-selected 11 migraine patients without aura (mean age=33.18 years, 
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8 females) to the 11 matched controls from the original 21 MO patients and 21 controls. 
However, the results in GM were considered significant for P<0.05, uncorrected for 
multiple comparisons. The areas investigated were the anterior cingulate cortex (ACC), 
amygdala, hippocampus, insula, intracalcarine cortex, and thalamus. 
 
Figure 2. Participant flow diagram from recruitment to analysis. 
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RESULTS 
 
 
 Voxel-based morphometry analysis of the whole brain showed no significant 
decreases in regional gray matter volume difference for migraine patients compared to 
control subjects when corrected for multiple comparisons. A significant corrected 
increase in regional gray matter volume difference was observed for migraine patients 
compared to control subjects in the intracalcarine gyrus of the visual cortex (Figure 4, 
Table 1, p<0.05). 
 Table 1. Montreal Neurological Institute (MNI) coordinates of significant volume 
increase between migraine patients and controls (corrected). 
 
 
 
 
Figure 3. Statistical parametric maps showing a significant volume increase between 
migraine patients and controls in the intracalcarine cortex. 
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In the VBM analysis of ROIs, numerous increases and decreases gray matter 
volume were detected at the uncorrected level (Tables 2-5). Clusters were reported if 
they were greater than 10 voxels. The similarities between the MO and MA subjects 
included increases in the ACC, hippocampus, insula, and IC, along with decreases in the 
ACC and insula. Differences were also observed between the MO and MA groups. MO 
subjects had decreases in the amygdala, hippocampus, intracalcarine cortex, and 
thalamus, but not in the MA subjects. The MA patients had increases in the amygdala and 
thalamus, but not in the MO patients. 
 
Table 2. MNI coordinates of significant increases in volume differences between MO 
patients and controls (uncorrected, p<0.05). 
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Figure 4. Largest clusters of increase in MO patients over controls. A) Cluster of 1534 
voxels in ACC. B) Cluster of 1642 in the intracalcarine cortex. 
 
 
 
 
Table 3. MNI coordinates of significant decreases in volume differences between MO 
patients and controls (uncorrected, p<0.05). 
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Figure 5. Clusters of decrease in MO patients over controls. Most clusters of decrease and 
largest cluster of decrease in the insula: A) two clusters of 356 and 227 voxels, B) cluster 
of 142 voxels, and C) cluster of 12 voxels; D) followed by cluster of 174 voxels in the 
amygdala. 
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Table 4. MNI coordinates of significant increases in volume differences between MA 
patients and controls (uncorrected, p<0.05). 
 
 
 
 
 
Figure 6. Largest clusters of increase in MA patients over controls. A) Cluster of 1569 
voxels in the intracalcarine cortex. B) Cluster of 431 voxels in the hippocampus. 
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Figure 7. Most clusters of increase for MA patients over controls. A) The ACC has 3 
clusters of 62, 48, and 43 voxels and B) the thalamus has 3 clusters of 173, 100, and 54 
voxels. 
 
 
 
Table 5. MNI coordinates of significant decreases in volume differences between MA 
patients and controls (uncorrected, p<0.05). 
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Figure 8. Largest cluster of decrease for MA patients over controls was in the insula with 
a cluster of 488 voxels. 
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DISCUSSION 
 
 The objective of this study was to assess the GM volume differences between 
migraine patients and healthy matched controls utilizing VBM in order to further the 
knowledge of migraine pathophysiology in the brain. Moreover, the heterogeneity within 
migraineurs was evaluated by performing VBM analyses in MO and MA patients 
compared to their respective controls, and then examining the similarities and differences 
between MO and MA patients.  
 
Changes in the Intracalcarine Gyrus 
The intracalcarine gyrus is an anatomical region located in the occipital lobe 
(Waxman, 2013). The primary visual cortex is situated above and below this area. Optic 
projections relay visual information through the lateral geniculate nucleus to the primary 
visual cortex where information about color, shape, motion, depth, and form is processed 
(Waxman, 2013). Most incoming visual signals enter the primary visual cortex, but there 
are other visual areas in the occipital, temporal, and parietal lobes where neurons are 
visually responsive (Waxman, 2013). 
In the primary comparison of migraine patients versus controls, a significant and 
large cluster of volume increase was found in the intracalcarine gyrus which is part of the 
visual cortex. In contrast, past studies have usually found decreases in GM volume 
difference when using VBM. Kim et al found decreases in the bilateral insula, 
motor/premotor, prefrontal, cingulate cortex, parietal cortex, and orbitofrontal cortex 
(Kim et al., 2008). In Liu et al, researchers performed a longitudinal study to assess GM 
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changes after 1 year in migraine patients without aura and identified GM reductions in 
the superior frontal gyrus, hippocampus, orbitofrontal cortex, precuneus, and primary and 
somatosensory cortices (Liu et al., 2013). Other studies have also found GM reductions in 
the cingulate cortex, insula, as well as the superior temporal gyrus, inferior frontal gyrus, 
and precentral gyrus (Schmidt-Wilcke et al., 2008; Tessitore et al., 2013). However, one 
study found an increase in the PAG and decreases mostly in the frontal and temporal 
lobes (Rocca et al., 2006). Still, others have found no changes in GM volume differences 
(Matharu et al., 2003; Tessitore et al., 2013). 
After finding a large cluster of increase in the intracalcarine gyrus, a sub-analysis 
was performed to determine if there were any differences within the migraine participants 
based on whether migraineurs experienced aura or not. This is because the cluster is in 
the visual cortex and MA patients experience visual disturbances, in addition to 
photophobia. Earlier studies have looked at the differences between MO and MA patients 
such as Granziera et al which found no differences between migraineurs, but an increase 
in cortical thickness of motion-processing visual areas V3A and MT+ (Granzeira et al., 
2006). Also, a surface-based morphometry analysis found no difference in cortical 
thickness between migraine patients with and without aura and matched controls (Datta et 
al., 2011). Thus, MO patients may experience silent aura where MO patients may have 
structural and functional brain similarities to MA patients, but none of the symptoms that 
MA patients commonly experience. 
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Other Brain Regions 
Along with the result from the VBM analysis of migraineurs compared to healthy 
controls, specific regions of interest were chosen based on previous knowledge of areas 
involved in pain processing such as ascending and descending modulation, sensory 
discriminative, and cognitive elements (Maleki et al., 2012; Schwedt et al., 2014). In 
fMRI studies, painful stimulation caused activation of areas in the thalamus, insula, 
cingulate cortex, amygdala, hippocampus, parahippocampus, cerebellum, brainstem, 
somatosensory, premotor, and prefrontal cortices (Moulton et al., 2011; Schwedt et al., 
2014). Further, headache-free resting state changes were evaluated using PET in 
migraineurs compared to controls (Kim et al., 2010). Hypometabolism was exhibited in 
the anterior and posterior cingulate, superior temporal, prefrontal, premotor, and primary 
somatosensory cortices in migraine patients. Additionally, pain regions were displayed in 
other studies evaluating functional and structural brain differences (Kim et al., 2008; 
Schwedt et al., 2013). 
In the ROI analysis of MO patients compared to controls, the largest clusters of 
increases in GM volume difference were in the ACC (1534 voxels) and the intracalcarine 
cortex (1642 voxels). The largest and most decreases were in the insula (356 and 227 
voxels), followed by the amygdala (174 voxels). More clusters of decrease were found in 
this group than in MA patients, 11 clusters of decrease to 4 clusters. The MA patients, 
compared to controls, had the largest increases in the intracalcarine cortex (1569 voxels) 
and the hippocampus (431 voxels). The most clusters of increase were in the ACC and 
thalamus, 3 clusters in each region. The largest decrease was in the insula (488 voxels). 
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There were more clusters of increase detected in the MA patients than in MO patients, 10 
clusters of decrease to 5 clusters. Large clusters of increase in the intracalcarine cortex 
was found in both MO and MA patients which may support the theory that MO patients 
experience a silent CSD, but this study did not scan patients during the ictal state which 
would be around the time-frame that MA, and possibly MO, patients would experience 
aura. Also, GM volume decreases in the insula of MO and MA patients backs previous 
experiments that identified GM reductions. In contrast, many GM volume increases were 
found in MA patients compared to controls, and some increases in MO patients, in 
regions where past studies have found GM volume decreases in migraine patients such as 
in the cingulate cortex, amygdala, hippocampus, and thalamus. 
From these results and past studies, it seems likely that the visual cortex is 
involved in the migraine mechanism, possibly related to photophobia experienced in both 
migraineurs with and without aura. Increased light sensitivity is reported interictally in 
75% of migraineurs (Main et al., 1997) and ictally in 60-90% of migraineurs (Noseda & 
Burstein, 2013; Vanagaite et al., 1997). A PET study examined cortical activity to visual 
stimulation in migraine patients and controls, both with and without concurrent 
trigeminal pain stimuli (Boulloche et al., 2010). Light stimuli activated the visual cortex 
in migraine patients but not controls when no painful stimulation was given. When a 
painful stimuli was used, the visual cortex was activated in the controls and displayed 
potentiated activation in migraine patients. Other studies give evidence for the interictal 
hyperexcitability of the occipital lobe, which houses the visual cortex, could be due to 
cortical hyperexcitability or dysfunctional adaptation to light intensity increases (Afra et 
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al., 1998; Aurora et al., 1998; Aurora et al., 1999; Aurora & Welch, 1998; Schoenen et 
al., 1995). When observing the occipital lobe specifically with fMRI, light discomfort 
was greater in migraine patients at all light intensities, but no correlation was detected 
between the number of activated voxels in the occipital lobe and the level of photophobia 
(Martín et al., 2011). Therefore, photoactivation in the cortex and photophobia may be 
separate processes which may explain why non-migraineurs still experience light 
discomfort (Martín et al., 2011). 
 
Limitations 
Several limitations are present in this study. Errors can be introduced during the 
processing steps. VBM is not able to distinguish between actual differences in tissue 
volume and local mis-registrations of images (Bookstein, 2001; Ashburner & Friston, 
2000). The precision of spatial normalization will differ across regions, so identifying 
volume differences accurately will vary across regions (Whitwell, 2009). Segmentation 
accuracy relies on the normalization quality. Also, segmentation can produce errors due 
to tissue displacement and partial volume effect between CSF and GM. However, 
utilizing customized templates reduces the occurrence of errors (Good et al., 2001) which 
is what this study employed. Since a multitude of voxels undergo statistical testing, false 
positives are reduced when using corrections for multiple comparisons. In our VBM 
analysis of migraine patients compared to controls, the family-wise error (FWE) 
correction was used which tends to be stricter than other methods available. However, we 
used uncorrected data in the ROI analysis, so there are potentially more false positive 
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results. Another limitation is differences across studies, which makes comparing our 
results to those in other studies more complicated. Other studies may use different image 
acquisition measurements like obtaining T2-weighted images or collecting a 
smaller/larger number of slices. Processing steps may also vary across studies. For 
instance, studies may use different registration algorithms and/or smoothing kernels. 
Also, disparate statistical analyses are employed such as applying different methods for 
correcting for multiple comparisons or using varying p values i.e. p<0.05 or p<0.01. 
These variations could change the number of voxels that rises above or falls below the 
significance threshold which may alter the conclusions of the study (Whitwell, 2009). 
Moreover, imaging studies have different numbers of subjects within migraine and 
control populations, larger cohorts having greater power to identify changes between 
groups. Confounders that may affect results are gender, age, ethnicity, as well as duration 
and frequency of migraine attacks. 
 
Conclusions 
Future imaging research should focus on creating more standard approaches to 
image acquisition, processing steps for FSL, and statistical analysis methods in order to 
more accurately assess changes in migraineurs compared to healthy individuals. Also, 
studies should aim to collect imaging data from larger cohorts of migraine patients and 
controls to increase the power of these studies. Other imaging analysis techniques should 
be employed in future studies to find structural and functional brain differences, such as 
using DTI and determining resting state networks from fMRI. Imaging analysis aspires to 
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more clearly determine migraine pathophysiology and will hopefully be used by 
clinicians in diagnosing individuals who may develop this condition. 
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